Mangiferin‐Encapsulated Lipid Carriers: Innovative strategy for Enhanced Brain Delivery in Alzheimer's Therapy
MGF-LCs demonstrated ideal properties for brain targeting, including nanoscale size, high Entrapment, and stability. RP-HPLC validated accurate quantification. These findings suggest that MGF-LCs can enhance bioavailability and serve as a promising intervention for AD. Further in vivo studies are essential to assess their neuroprotective efficacy and confirm their therapeutic potential.
Authors
- Krishnadas Nandakumar (ORCID: https://orcid.org/0000-0001-6653-4660)
- Pawan G. Nayak (ORCID: https://orcid.org/0000-0001-5525-9982)
- Akshatha Kamath (ORCID: https://orcid.org/0000-0002-9279-9280)
Institutions
- Manipal Academy of Higher Education (IN)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70861_108327
- Primary Topic
- Mangiferin and Mango Extracts
- Type
- article
- Field-Weighted Citation Impact
- 0.00